Having a partner in life can boost survival chances of people with cancer than for patients living without a partner.
Increasing Breast Cancer Survival by 5 Extra Months
The cancer drug eribulin has been originally developed from sea sponges. It could give women with advanced triple negative breast cancer an average of 5 extra months to live.
The cancer drug eribulin has been originally developed from sea sponges. It could give women with advanced triple negative breast cancer an average of 5 extra months to live.
‘Cancer patients who are single are more likely to die within 10 years than those with a partner.’
The study found that 26% of single men are more likely to die within 10 years than partnered men and 20% of single women die early than partnered women. But the reasons for the early death remained unclear. Cancer Council Queensland CEO Professor Jeff Dunn said, “There was a range of possible explanations. Environmental factors, economic factors, psychosocial factors and, of course, all those other sorts of things that go with having a partner.”
Source-Medindia
Cancer Survival Rates Not Improved by Double Mastectomy: Study
Women with cancer in one breast do not find it beneficial to have both breasts removed, suggests a new research out Tuesday, and that targeted surgery plus radiation was equally effective.
Women with cancer in one breast do not find it beneficial to have both breasts removed, suggests a new research out Tuesday, and that targeted surgery plus radiation was equally effective.
Cancer Survival Rates Vary Significantly Among Some Countries
The biggest global study comparing the cancer survival rates has found a dramatic gulf in the survival rates between different countries.
The biggest global study comparing the cancer survival rates has found a dramatic gulf in the survival rates between different countries.
Breast Cancer Prognosis may be Predicted by Protein
A protein that may help predict breast cancer prognosis has been identified in a new research.
A protein that may help predict breast cancer prognosis has been identified in a new research.
